Amgen, J&J anemia drugs recalled over glass flakes
What’s the problem?
September 24, 2010 – This week, Amgen Inc. announced that it is recalling several hundred lots of anemia drugs Epogen and Procrit – sold by Johnson & Johnson – because vials of the injectable medicines might develop tiny glass flakes that could cause blood clots and other serious health problems. According to Amgen, the glass flakes result from the interaction of the drug with glass vials over the shelf life of the product.
Amgen sells Epogen in the United States, where it is used mostly for kidney dialysis patients. Under a long-standing license from Amgen, J&J’s Centocor Ortho Biotech unit distributes Procrit in the United States, mainly for cancer and HIV patients. J&J is currently dealing with a rash of recalls of its consumer medicines.